Urological Disorders Therapeutics to 2017 – Large Number of Licensing Deals – PRLog (free press release)

Important drugs that have recently lost patent protection include Flomax (tamsulosin, 2009) and Levaquin (levofloxacin, 2010). Those set to lose patent protection in the forecast period include Uroxatral in the US (alfuzosin, 2011), Detrol (tolterodine …

Leave a Reply

Your email address will not be published.

*